- AU$414.26m
- AU$450.83m
- $0.11m
C2019 June 30th | R2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.114 | 0.059 | 0.069 | 0.091 | 0.108 |
Cost of Revenue | |||||
Gross Profit | -0.082 | -0.298 | -0.36 | -0.07 | -0.058 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 26.4 | 17.1 | 39.7 | 96.7 | 150 |
Operating Profit | -26.3 | -17.1 | -39.7 | -96.6 | -150 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -25.4 | -16.8 | -50.3 | -99.1 | -148 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14.9 | -11.1 | -45.3 | -92.8 | -143 |
Net Income Before Extraordinary Items | |||||
Net Income | -14.9 | -11.1 | -45.3 | -92.8 | -143 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14.9 | -11.1 | -45.3 | -92.8 | -143 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.061 | -0.04 | -0.133 | -0.249 | -0.304 |